Form 8-K - Current report:
SEC Accession No. 0001193125-25-317532
Filing Date
2025-12-12
Accepted
2025-12-12 16:03:50
Documents
10
Period of Report
2025-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20251211.htm   iXBRL 8-K 61622
  Complete submission text file 0001193125-25-317532.txt   182368

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20251211.xsd EX-101.SCH 32981
12 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20251211_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 251568024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)